Ovulation Induction Medication and Follicle Monitoring: Stimulation Injections, Follicle Size and Trigger Timing

Written by the DanRuo Hospital medical content team | Last updated: 1 October 2026 · Protocols and medication are always decided by an individualised clinical assessment.

Ovulation induction is the preparation stage before egg retrieval; during the cycle the medication, the monitoring visits and the timing of the trigger injection are all interlinked. This page explains how the stimulation injections are given and for how many days, how starting them at home before travel can be coordinated, how follicle monitoring is interpreted, and how the trigger injection and retrieval are scheduled in time. The actual medication protocol must be designed by the physician according to your individual situation.

How the stimulation injections are given, and for how many days

How are the stimulation injections for egg retrieval given? Do I inject myself or does a clinic do it?

Ovulation induction medications are mostly subcutaneous injections (a few are intramuscular). The usual injection sites are the abdomen (away from the navel) or the outer thigh. In clinical practice a rotary pre-filled adjustable pen is commonly used, allowing patients to inject themselves subcutaneously at home; the needle is fine and short, and the medication must be refrigerated and protected from light. After instruction by a nurse, most patients inject themselves or are helped by a family member; if self-injection is not convenient, it can also be arranged at a medical facility with a nurse performing the injection. The nursing instruction and support the hospital provides should be confirmed at your pre-treatment consultation.

How many days do the stimulation injections take? Can I start them at home before travelling to Cambodia?

At our hospital, ovarian stimulation and follicle monitoring generally take about 10-12 days; after retrieval, embryo culture and genetic screening take about 5-7 days, after which a fresh or frozen embryo transfer can be scheduled. The actual number of days still depends on the medication protocol, the speed of follicle growth and your individual response. To reduce the number of days spent in Cambodia, some patients complete the early medication and monitoring at home first, then come to Cambodia for the later part of the treatment and retrieval - this is a common arrangement, but it needs advance planning and the agreement of the physicians at both ends. Whether you can start injecting at home, and how the handover and monitoring will work, should be confirmed with our physicians at your pre-treatment consultation.

Which ovulation induction protocols and medications does the hospital commonly use?

The ovulation induction protocols commonly used at our hospital include the PPOS protocol, luteal-phase stimulation (LPS), mild stimulation protocols, and modified versions of the above, mainly for patients aged over 38 or with AMH below 1; for patients under 35 with normal ovarian reserve, a standard antagonist protocol or the long protocol is generally used. Common medications are Gonal-f, Puregon and Menopur; the trigger injection (night injection) is Ovidrel or Diphereline. The actual protocol and medications are decided by the physician according to your test results and individual response - there is no single fixed combination.

What should I do if I forget an injection or take the wrong dose?

If a dose is missed or the dose is wrong, contact the medical team as soon as possible; the physician will decide whether to make up the dose or adjust, based on the progress of the cycle and the follicle situation. Never double the dose on your own. Try to keep the injection time fixed (any error should be measured in hours, not carried over to the next day). We suggest setting reminders and keeping a medication record to show the physician at your review appointments.

How follicle monitoring is interpreted

When follicles are tracked by ultrasound, how large must they be before egg retrieval can be scheduled?

The judgement is generally based on the mean follicle diameter measured by ultrasound; most fertility centres arrange the ovulation trigger (the trigger injection) when the leading follicle cohort reaches about 17-20 mm. The actual criterion is adjusted according to the medication protocol, the number of follicles, the oestradiol level and your individual situation - it is never decided by a single number alone.

What does follicle size mean? How should follicle number and quality be assessed?

Follicle size reflects the maturity of the follicle and is one of the indicators used to decide the timing of retrieval; the follicle count (such as the antral follicle count, AFC) reflects the ovarian reserve and is usually assessed together with age, AMH and other markers. It is important to note that the number of follicles does not equal egg quality, nor does it equal the number of usable embryos - an egg is not obtained from every follicle, and not every egg retrieved will fertilise or develop into a good embryo. The physician assesses ultrasound findings, hormone levels and age together, and never relies on a single indicator.

How often do I need to return for monitoring during ovulation induction?

During ovulation induction several review visits are usually needed. At each visit a transvaginal ultrasound measures follicle size and number, and blood tests for oestradiol (E2), progesterone (P) and other values are taken as needed; the medication dose is adjusted according to the results. Reviews are generally every 1-3 days, becoming more frequent as retrieval approaches. For patients who start their injections at home, the monitoring arrangements are coordinated in advance - please confirm them at your pre-treatment consultation.

The trigger injection and the timing of retrieval

When is the trigger injection given, and how long after it is retrieval performed?

The trigger injection (ovulation trigger) is given once the follicles are mature; its purpose is to let the eggs complete their final maturation step so that they can be retrieved smoothly at egg retrieval. The medications commonly used at our hospital are hCG (such as Ovidrel) or a GnRH agonist (such as Diphereline); for patients with a high ovarian response, a GnRH agonist trigger is usually used instead, to lower the risk of ovarian hyperstimulation syndrome (OHSS). Retrieval is generally scheduled about 34-36 hours after the injection. The timing is measured in minutes: the injection must be given strictly at the time specified by the physician and should not be brought forward or delayed. Injecting too early or too late can both affect the retrieval outcome, which is why the timing is decided by the physician according to the follicle and hormone values, and patients must follow the specified time exactly.

What happens if the trigger injection is given at the wrong time?

The trigger time is calculated by working backwards from the time the eggs need to mature. If the injection time differs too much from the scheduled retrieval time, the eggs may not yet be mature or may already have been released prematurely, affecting the number of eggs retrieved and the subsequent fertilisation results. So if you discover a timing error, contact the medical team immediately; the physician will assess whether to adjust the retrieval time or the plan.

The hospital's protocols for advanced age and poor response: PPOS and LPS

What is the PPOS protocol, and who is it suitable for?

PPOS (Progestin-Primed Ovarian Stimulation) uses oral progestogen during stimulation; through the negative feedback of progestogen on the hypothalamus-pituitary axis it suppresses the LH surge and prevents premature ovulation, while gonadotrophins stimulate follicle growth. The advantages of this protocol are simpler medication, no need for down-regulation injections, and fewer stimulation days and lower drug volumes. For patients of advanced age (over 38), with low ovarian reserve (AMH below 1), or who responded poorly to conventional protocols in the past, it is a common option. The specific drug combination and doses used for PPOS at our hospital are decided by the physician according to AMH, AFC and the response to previous cycles.

What is luteal-phase stimulation (LPS), and how does it differ from PPOS?

Luteal-phase stimulation (LPS) starts stimulation in the luteal phase of the menstrual cycle (after ovulation), making use of the more stable hormonal environment of the luteal phase, combined with an oral contraceptive or progestogen to suppress dominant follicle selection so that multiple small follicles grow synchronously. The difference from PPOS lies in the starting point and the logic of hormonal control: PPOS starts in the follicular phase and suppresses LH with oral progestogen; LPS starts in the luteal phase and uses the cycle's own hormonal state. Both are suitable for poor ovarian responders and can form part of an egg accumulation strategy - two retrievals within the same cycle, or accumulating embryos across cycles. Which protocol is actually used, and whether growth hormone or other adjunct medication is added, is assessed by the physician according to your individual situation.

For patients of advanced age or with low AMH, what is Dan Ruo's stimulation strategy?

For patients over 38 or with AMH below 1, the strategies commonly used at our hospital include: (1) PPOS or LPS protocols, which reduce drug volumes while maintaining follicular synchrony; (2) adding growth hormone (GH) where appropriate, to improve egg quality and fertilisation rates; (3) an egg accumulation strategy - double stimulation (DuoStim) within the same cycle or multiple retrievals across cycles, accumulating enough embryos before PGT screening and transfer. Dan Ruo also offers a two-year unlimited retrieval plan: you can start with one retrieval and, if another is needed, pay the difference to convert to a plan with unlimited retrievals over two years to accumulate embryos, reducing the financial pressure on patients of advanced age. The actual plan should be assessed by the physician based on your test reports.

For a personalised treatment assessment, a cost breakdown, or medication and test checklists, call +86 400 618 5161 or email info@incitaivf.com.

Book a one-to-one fertility assessment Cost guide FAQ

Further reading: FAQ | PGT euploidy rates and success rates | Cost ranges | Validity of test reports | Egg retrieval surgery and anaesthesia | Interpreting pre-treatment reports | Choosing a sperm bank | Travel and preparation

This article is general health information and does not constitute medical advice, diagnosis or a guarantee of any outcome. Medication protocols, doses and timings vary between individuals; your specific plan should be based on an assessment by a reproductive physician.

400-618-5161
LINE QR code
WhatsApp QR code
WeChat QR code
Telegram QR code